
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. Keeping that in mind, here are three small-cap stocks to swipe left on and some alternatives you should look into instead.
Latham (SWIM)
Market Cap: $607 million
Started as a family business, Latham (NASDAQ:SWIM) is a global designer and manufacturer of in-ground residential swimming pools and related products.
Why Are We Out on SWIM?
- Sales trends were unexciting over the last five years as its 6.2% annual growth was below the typical consumer discretionary company
- Operating margin of 4.6% falls short of the industry average, and the smaller profit dollars make it harder to react to unexpected market developments
- Forecasted free cash flow margin suggests the company will fail to improve its cash conversion over the next year
At $5.40 per share, Latham trades at 27.7x forward P/E. Read our free research report to see why you should think twice about including SWIM in your portfolio.
Hexcel (HXL)
Market Cap: $6.01 billion
Founded shortly after World War II by a group of engineers from UC Berkley, Hexcel (NYSE:HXL) manufactures lightweight composite materials primarily for the aerospace and defense sectors.
Why Does HXL Give Us Pause?
- Sales trends were unexciting over the last two years as its 2.9% annual growth was below the typical industrials company
- Earnings per share have contracted by 1.4% annually over the last two years, a headwind for returns as stock prices often echo long-term EPS performance
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
Hexcel is trading at $79.70 per share, or 35.4x forward P/E. Check out our free in-depth research report to learn more about why HXL doesn’t pass our bar.
Option Care Health (OPCH)
Market Cap: $4.30 billion
With a nationwide network of 177 locations serving 43 states and a team of over 4,500 clinicians, Option Care Health (NASDAQ:OPCH) is the largest independent provider of home and alternate site infusion services, delivering medications and clinical support to patients across the United States.
Why Does OPCH Fall Short?
- Free cash flow margin shrank by 1.5 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive
Option Care Health’s stock price of $27.04 implies a valuation ratio of 14.7x forward P/E. To fully understand why you should be careful with OPCH, check out our full research report (it’s free).
Stocks We Like More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.